Independent Investment Manager Sells $24.6 Million of Exponent Stock, According to Recent Filing

Core Insights - Conestoga Capital Advisors, LLC sold 344,631 shares of Exponent, valued at approximately $24.63 million, reducing its stake in the company [1][2][10] - Exponent now represents 2.63% of Conestoga's 13F AUM, down from 2.99% in the previous quarter [2][3] Company Overview - Exponent is a leading provider of multidisciplinary consulting services, focusing on scientific and engineering expertise to solve technical and regulatory challenges [5][6] - The company operates across approximately 90 technical disciplines, including biomechanics, civil engineering, and data sciences, utilizing a fee-for-service business model [6][14] Financial Performance - As of September 30, 2025, Exponent reported a revenue of $560.51 million and a net income of $102.84 million, with a dividend yield of 1.70% [4] - The share price of Exponent as of October 23, 2025, was $68.96, reflecting a 35.61% decline year-to-date [3][4] Market Position - Exponent has underperformed the S&P 500 by 50.09 percentage points over the past year, with a year-to-date decline of 21% compared to a nearly 17% increase in the S&P 500 [3][11] - The company serves a diversified client base across various industries, including chemical, construction, and life sciences, which enhances its competitive advantage [7][5]